| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |